Diyuan Xue

Tumor-conditional IL-15 pro-cytokine reactivates anti-tumor immunity with limited toxicity

yang-xin fu, Jiankun Zhu, Yong Liang, 2021, Cell Research.

T Cell-Derived Lymphotoxin Is Essential for the Anti-Herpes Simplex Virus 1 Humoral Immune Response

Zhichen Sun, yang-xin fu, Mingzhao Zhu, 2018, Journal of Virology.

Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression

Zhichen Sun, yang-xin fu, Kaiting Yang, 2017, Cancer Immunology Research.

A tumor-specific pro-IL-12 activates preexisting cytotoxic T cells to control established tumors

yang-xin fu, Shuaishuai Cao, Yang Wang, 2022, Science Immunology.

Next-generation cytokines for cancer immunotherapy

yang-xin fu, Hua Peng, Eric J Hsu, 2021, Antibody therapeutics.

An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis delivery

Yangbo Fu, Yong Liang, Jingya Guo, 2022, The Journal of experimental medicine.

Anti-PD-1 cis-delivery of low-affinity IL-12 activates intratumoral CD8+T cells for systemic antitumor responses

Yangbo Fu, Hua Peng, Diyuan Xue, 2024, Nature communications.